DEA's No. 2 official resigns over Big Pharma consulting work, raising concerns about revolving door

Louis Milione, the DEA's second-in-command, resigned after his past consulting work for pharmaceutical companies was revealed.
Milione consulted for a drug distributor and Purdue Pharma, which faced lawsuits over its marketing of OxyContin.
His consulting work has renewed concerns about the "revolving door" between government and industry.
Milione returned to the DEA in 2021 without congressional oversight, avoiding scrutiny of potential conflicts of interest.
His departure comes amid turnover and misconduct issues at the top levels of the DEA.